Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma

Cancer Letters

Volumn 238, Issue 2, 2006, Pages 240-247

  Bøhn, Siv Kjølsrud ^a   Smeland, Sigbjørn ^b   Sakhi, Amrit Kaur ^a   Thoresen, Magne ^a   Russnes, Kjell Magne ^b   Tausjø, Johan ^b   Svilaas, Arne ^b   Svilaas, Tone ^b   Blomhoff, Rune ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Glutathione; Head and neck squamous cell carcinoma; Oxidative stress; Radiotherapy; Thiols

Indexed keywords

GLUTATHIONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; GLUTATHIONE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED;

EID: 33745066831     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.07.027     Document Type: Article

References (50)

1. Cooper C.E., Patel R.P., Brookes P.S., and Darley-Usmar V.M. Nanotransducers in cellular redox signaling: modification of thiols by reactive oxygen and nitrogen species. Trends Biochem. Sci. 27 (2002) 489-492
2. Deplancke B., and Gaskins H.R. Redox control of the transsulfuration and glutathione biosynthesis pathways. Curr. Opin. Clin. Nutr. Metab. Care 5 (2002) 85-92
3. Dickinson D.A., and Forman H.J. Cellular glutathione and thiols metabolism. Biochem. Pharmacol. 64 (2002) 1019-1026
4. Sies H. Glutathione and its role in cellular functions. Free Radic. Biol. Med. 27 (1999) 916-921
5. Schafer F.Q., and Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30 (2001) 1191-1212
6. Sheehan D., Meade G., Foley V.M., and Dowd C.A. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem. J. 360 (2001) 1-16
7. Keppler D. Export pumps for glutathione S-conjugates. Free Radic. Biol. Med. 27 (1999) 985-991
8. Nordberg J., and Arner A.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31 (2001) 1287-1312
9. Wild A.C., and Mulcahy R.T. Regulation of gamma-glutamylcysteine synthetase subunit gene expression: insights into transcriptional control of antioxidant defenses. Free Radic. Res. 32 (2000) 281-301
10. Hayes J.D., and McLellan L.J. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic. Res. 31 (1999) 273-300
11. Whitfield J.B. Gamma glutamyl transferase. Crit. Rev. Clin. Lab. Sci. 38 (2001) 263-355
12. Therond P., Bonnefont-Rousselot D., Davit-Spraul A., Conti M., and Legrand A. Biomarkers of oxidative stress: an analytical approach. Curr. Opin. Clin. Nutr. Metab. Care 3 (2000) 373-384
13. Nuttall S.L., Martin U., Sinclair A.J., and Kendall M.J. Glutathione: in sickness and in health. Lancet 351 (1998) 645-646
14. Jones D.P., Carlson J.L., Samiec P.S., et al. Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin. Chim. Acta 275 (1998) 175-184
15. Lang C.A., Mills B.J., Mastropaolo W., and Liu M.C. Blood glutathione decreases in chronic diseases. J. Lab. Clin. Med. 135 (2000) 402-405
16. Seidman M.D., Quirk W.S., and Shirwany N.A. Reactive oxygen metabolites, antioxidants and head and neck cancer. Head. Neck 21 (1999) 467-479
17. Poulsen H.E., Prieme H., and Loft S. Role of oxidative DNA damage in cancer initiation and promotion. Eur. J. Cancer Prev. 7 (1998) 9-16
18. Tatebe S., Unate H., Sinicrope F.A., et al. Expression of heavy subunit of gamma-glutamylcysteine synthetase (gamma- GCSh) in human colorectal carcinoma. Int. J. Cancer 97 (2002) 21-27
19. Stanulla M., Schrappe M., Brechlin A.,M., Zimmermann M., and Welte K. Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study. Blood 95 (2000) 1222-1228
20. Davies S.M., Robison L.L., Buckley J.D., et al. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J. Clin. Oncol. 19 (2001) 1279-1287
21. Kearns P.R., Pieters R., Rottier M.M., Pearson A.D., and Hall A.G. Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia. Blood 97 (2001) 393-398
22. Riley P.A. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int. J. Radiat. Biol. 65 (1994) 27-33
23. Ladner R.D. The role of dUTPase and uracil-DNA repair in cancer chemotherapy. Curr. Protein Pept. Sci. 2 (2001) 361-370
24. Brahme A., Nilsson J., and Belkic D. Biologically optimized radiation therapy. Acta. Oncol. 40 (2001) 725-734
25. Sturgis E.M., and Wei Q. Genetic susceptibility-molecular epidemiology of head and neck cancer. Curr. Opin. Oncol. 14 (2002) 310-317
26. Bailey S.M. A review of the role of reactive oxygen and nitrogen species in alcohol-induced mitochondrial dysfunction. Free Radic. Res. 37 (2003) 585-596
27. Mork J., Lie A.K., Glattre E., et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 344 (2001) 1125-1131
28. Geisler S.A., and Olshan A.F. GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. Am. J. Epidemiol. 154 (2001) 95-105
29. Droge W., Eck H.P., and Mihm S. HIV-induced cysteine deficiency and T-cell dysfunction-a rationale for treatment with N-acetylcysteine. Immunol. Today 13 (1992) 211-214
30. Yim C.Y., Hibbs Jr. J.B., McGregor J.R., Galinsky R.E., and Samlowski W.E. Use of N-acetyl cysteine to increase intracellular glutathione during the induction of antitumor responses by IL-2. J. Immunol. 152 (1994) 5796-5805
31. Hargrove M.E., Wang J., and Ting C.C. Regulation by glutathione of the activation and differentiation of IL-4-dependent activated killer cells. Cell. Immunol. 149 (1993) 433-443
32. Iwata S., Hori T., Sato N., et al. Thiol-mediated redox regulation of lymphocyte proliferation. Possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression. J. Immunol. 152 (1994) 5633-5642
33. Chen G., Wang S.H., and Converse C.A. Glutathione increases interleukin-2 production in human lymphocytes. Int. J. Immunopharmacol. 16 (1994) 755-760
34. Jeannin P., Delneste Y., Lecoanet-Henchoz S., et al. Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis. J. Exp. Med. 182 (1995) 1785-1792
35. Tsuyuki S., Yamauchi A., Nakamura H., et al. Possible availability of N-acetylcysteine as an adjunct to cytokine therapy for hepatocellular carcinoma. Clin. Immunol. Immunopathol. 88 (1998) 192-198
36. Tsuyuki S., Yamauchi A., Nakamura H., et al. N-acetylcysteine improves cytotoxic activity of cirrhotic rat liver-associated mononuclear cells. Int. Immunol. 10 (1998) 1501-1508
37. Peterson J.D., Herzenberg L.A., Vasquez K., and Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. FASEB J. 95 (1998) 3071-3076
38. Kinscherf R., Fischbach T., Mihm S., et al. Effect of glutathione depletion and oral N-acetyl-cysteine treatment on CD4+ and CD8+ cells. FASEB J. 8 (1994) 448-451
39. Whiteside T.L., Vujanovic N.L., and Herberman R.B. Natural killer cells and tumor therapy. Curr. Top. Microbiol. Immunol. 230 (1998) 221-244
40. Staal F.J., Roederer M., Israelski D.M., et al. Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals, AIDS Res. Hum. Retroviruses 8 (1992) 305-311
41. Herzenberg L.A., De Rosa S.C., Dubs J.G., et al. Glutathione deficiency is associated with impaired survival in HIV disease. FASEB J. 94 (1997) 1967-1972
42. Muller F., Svardal A.M., Nordoy I., Berge R.K., Aukrust P., and Froland S.S. Virological and immunological effects of antioxidant treatment in patients with HIV infection. Eur. J. Clin. Invest. 30 (2000) 905-914
43. De Rosa S.C., Zaretsky M.D., Dubs J.G., et al. N-acetylcysteine replenishes glutathione in HIV infection. Eur. J. Clin. Invest. 30 (2000) 915-929
44. Breitkreutz R., Pittack N., Nebe C.T., et al. Improvement of immune functions in HIV infection by sulfur supplementation: two randomized trials. J. Mol. Med. 78 (2000) 55-62
45. Kojima S., Ishida H., Takahashi M., and Yamaoka K. Elevation of glutathione induced by low-dose gamma rays and its involvement in increased natural killer activity. Radiat. Res. 157 (2002) 275-280
46. Jones D.P. Redox potential of GSH/GSSG couple: assay and biological significance. Meth. Enzymol. 348 (2002) 93-112
47. Ono H., Sakamoto A., and Sakura N. Plasma total glutathione concentrations in epileptic patients taking anticonvulsants. Clin. Chim. Acta 298 (2000) 135-143
48. Jones D.P., Carlson J.L., Mody V.C., Cai J., Lynn M.J., and Sternberg P. Redox state of glutathione in human plasma. Free Radic. Biol. Med. 28 (2000) 625-635
49. Jadhav G.K., Bhanumathi P., Uma D.P., et al. Possible role of glutathione in predicting radiotherapy response of cervix cancer. Int. J. Radiat. Oncol. Biol. Phys. 41 (1998) 3-5
50. Bhuvarahamurthy V., Balasubramanian N., and Govindasamy S. Effect of radiotherapy and chemoradiotherapy on circulating antioxidant system of human uterine cervical carcinoma. Mol. Cell. Biochem. 158 (1996) 17-23